Keros Therapeutics Inc (KROS)

Operating Income Growth

-32621.79%

TTM · Period ending:

KROS logo

KROS Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-32621.79%
KROS TTM Operating Income YoY % (-341.70% → -32621.79%)
High-resolution chart · PNG

KROS operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Keros Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-32,621.7949%
-970.3007%
132.0486%
121.3616%
100.1654%
94.258%
-24.0625%
-31.2572%
-34.6185%
-38.6172%
-48.0451%
-77.2555%
-75.3594%
-100.1128%
-103.6258%
-35.3375%
-41.3235%
-24.6678%
-20.8243%
-79.5257%
-113.6182%
-185.1447%
-341.7022%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.